Skip to main content
. 2022 Apr 25;12(5):389. doi: 10.3390/metabo12050389

Figure 4.

Figure 4

Screening of marker metabolites in SCC-9 cells stimulated by cisplatin. OPLS-DA analysis (A). S-plot analysis (B). Relative abundance of marker metabolites (C). SCC9_0, SCC9_1 and SCC9_2 represent the SCC-9 cells treated with cisplatin for 0 h, 24 h or 48 h. **, p < 0.01.